Posted by Michael Wonder on 27 Aug 2020
Mylan, Lupin launch etanercept biosimilar in Germany
26 August 2020 - The launch marks the first European market entry for Nepexto.
Germany is the first country in Europe to have Nepexto enter the market, according to Maximilian von Wülfing, managing director of Mylan Germany.
Nepexto is the second immunology product to launch on the German market and the third etanercept biosimilar to receive regulatory approval in Europe, after the first was approved in 2016.
